{"id":1165319,"date":"2024-06-04T04:30:38","date_gmt":"2024-06-04T08:30:38","guid":{"rendered":"https:\/\/www.statnews.com\/?p=1165319"},"modified":"2024-06-04T20:15:28","modified_gmt":"2024-06-05T00:15:28","slug":"fda-advisory-panel-mdma-therapy-ptsd","status":"publish","type":"post","link":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/","title":{"rendered":"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD"},"content":{"rendered":"

In a surprisingly strong rejection of the first psychedelic therapy to come before the Food and Drug Administration, a scientific advisory panel on Tuesday overwhelmingly voted against the use of MDMA for treating PTSD, putting its approval in doubt.<\/p>\n

At the end of a nine-hour meeting marked by sometimes-emotional testimony, the advisory committee voted 9-2 that the data do not show MDMA is effective in treating PTSD. The decision came after members critiqued the methodology of clinical trials by Lykos Therapeutics, which is seeking FDA approval for MDMA, and therapist oversight, rather than the drug itself.<\/p>\n

The committee also voted 10-1 against a second question, on whether the benefits of MDMA outweighed the risks under the FDA’s proposed REMS program, a set of conditions placed on a drug to mitigate possible patient harms.<\/p>","protected":false},"excerpt":{"rendered":"

An FDA advisory committee is meeting today to review MDMA-assisted psychotherapy to treat PTSD. Follow STAT’s live blog throughout the day for updates.<\/p>\n","protected":false},"author":453,"featured_media":1066056,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"stat_display_restriction_not_latest":false,"stat_featured_image_caption":"","stat_featured_image_nocrop":false,"stat_featured_image_focal_point":{"x":0.5,"y":0.5},"stat_article_wordmark_img":[],"stat_article_wordmark_url":"","stat_article_wordmark_height":"125px","stat_article_wordmark_enable":false,"stat_article_subheadline":"","stat_paywall_restrict":true,"footnotes":"","stat_article_enhanced_byline":"","stat_article_newsletter_id":"","stat_article_header_color_scheme":"","_yoast_wpseo_primary_category":5318,"stat_paywall_move_flag":0},"categories":[5318],"tags":[294,1047,202512,5393],"authors":[198346,3054],"class_list":["post-1165319","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma","tag-fda","tag-mental-health","tag-psychedelics","tag-stat-plus"],"featured_image_src":"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065-1024x576.jpeg","coauthors":[{"avatar":"\"Olivia","display_name":"Olivia Goldhill","author_page":"https:\/\/www.statnews.com\/staff\/olivia-goldhill\/","first_name":"Olivia","title":"Contributing Writer","bio":"Olivia Goldhill focused primarily on covering the health crisis affecting American boys and men. She also covered psychedelic medicines.","email_address":"olivia.goldhill@statnews.com","email_url":"mailto:olivia.goldhill@statnews.com","twitter_url":"https:\/\/x.com\/OliviaGoldhill","twitter_handle":"@OliviaGoldhill","facebook_url":"","linkedin_url":"","web_url":"","bluesky_url":"","bluesky_handle":""},{"avatar":"\"Meghana","display_name":"Meghana Keshavan","author_page":"https:\/\/www.statnews.com\/staff\/meghana-keshavan\/","first_name":"Meghana","title":"Biotech Correspondent","bio":"Meghana Keshavan covers biotech and contributes to The Readout newsletter<\/a>.","email_address":"meghana.keshavan@statnews.com","email_url":"mailto:meghana.keshavan@statnews.com","twitter_url":"https:\/\/x.com\/megkesh","twitter_handle":"@megkesh","facebook_url":"","linkedin_url":"","web_url":"","bluesky_url":"","bluesky_handle":""}],"stat_card_curation":{"image_id":1066056,"title":"","excerpt":"","video_id":0,"disable_topic_image_curation":false},"template_inline_styles":[],"stat_byline_classes":["article-byline","multi-author"],"use_block_editor_for_post":false,"stat_featured_video":null,"yoast_head":"\nMDMA therapy for PTSD voted down by FDA advisory panel | STAT<\/title>\n<meta name=\"description\" content=\"FDA advisers weigh the first use of psychedelic therapy for post-traumatic stress disorder, review safety and efficacy data from MDMA trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD\" \/>\n<meta property=\"og:description\" content=\"An FDA advisory committee is meeting today to review MDMA-assisted psychotherapy to treat PTSD. Follow STAT's live blog throughout the day for updates.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\" \/>\n<meta property=\"og:site_name\" content=\"STAT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/statnews\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-04T08:30:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-05T00:15:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065-1024x576.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Olivia Goldhill, Meghana Keshavan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OliviaGoldhill\" \/>\n<meta name=\"twitter:site\" content=\"@statnews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Olivia Goldhill, Meghana Keshavan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"31 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\"},\"author\":{\"name\":\"Olivia Goldhill\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/person\/1015d5fce9ad8ee748ec30c3c2a6cd72\"},\"headline\":\"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD\",\"datePublished\":\"2024-06-04T08:30:38+00:00\",\"dateModified\":\"2024-06-05T00:15:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\"},\"wordCount\":7065,\"publisher\":{\"@id\":\"https:\/\/www.statnews.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg\",\"keywords\":[\"FDA\",\"Mental Health\",\"psychedelics\",\"STAT+\"],\"articleSection\":[\"Pharma\"],\"inLanguage\":\"en-US\",\"isAccessibleForFree\":\"False\",\"hasPart\":{\"@type\":\"WebPageElement\",\"isAccessibleForFree\":\"False\",\"cssSelector\":\".restricted-content-text\"},\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.statnews.com\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\",\"url\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\",\"name\":\"MDMA therapy for PTSD voted down by FDA advisory panel | STAT\",\"isPartOf\":{\"@id\":\"https:\/\/www.statnews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg\",\"datePublished\":\"2024-06-04T08:30:38+00:00\",\"dateModified\":\"2024-06-05T00:15:28+00:00\",\"description\":\"FDA advisers weigh the first use of psychedelic therapy for post-traumatic stress disorder, review safety and efficacy data from MDMA trials.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage\",\"url\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg\",\"contentUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg\",\"width\":4608,\"height\":2592,\"caption\":\"MDMA-Assisted Psychotherapy for PTSD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.statnews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.statnews.com\/#website\",\"url\":\"https:\/\/www.statnews.com\/\",\"name\":\"STAT\",\"description\":\"A decade of reporting from the frontiers of health and medicine\",\"publisher\":{\"@id\":\"https:\/\/www.statnews.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.statnews.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.statnews.com\/#organization\",\"name\":\"STAT\",\"url\":\"https:\/\/www.statnews.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png\",\"contentUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png\",\"width\":150,\"height\":41,\"caption\":\"STAT\"},\"image\":{\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/statnews\/\",\"https:\/\/x.com\/statnews\",\"https:\/\/www.linkedin.com\/company\/stat-news\/\",\"https:\/\/www.youtube.com\/channel\/UC89FjSf9AT1O2qw6vxrrxDQ\"],\"description\":\"STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories from the places that matter to our readers \u2014 research labs, hospitals, executive suites, and political campaigns.\",\"legalName\":\"STAT\",\"foundingDate\":\"2015-11-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/person\/1015d5fce9ad8ee748ec30c3c2a6cd72\",\"name\":\"Olivia Goldhill\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/person\/image\/5ddade59f324409939901b2bc344abeb\",\"url\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/olivia-g-profile-96x96.png\",\"contentUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/olivia-g-profile-96x96.png\",\"caption\":\"Olivia Goldhill\"},\"description\":\"Olivia Goldhill is a former contributing writer for STAT, focused primarily on covering the health crisis affecting American boys and men. She also covers psychedelic medicines. Previously, she was an investigative reporter at STAT, and covered mental health, reproductive health, and the Covid-19 pandemic. Her work has been recognized with Livingston, EPPY, British Journalism, and Medical Journalists\u2019 Association award nominations, and she was a 2024 New America National Fellow, supported by the Jonathan Logan Family Foundation.\",\"sameAs\":[\"https:\/\/x.com\/OliviaGoldhill\"],\"url\":\"https:\/\/www.statnews.com\/staff\/olivia-goldhill\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MDMA therapy for PTSD voted down by FDA advisory panel | STAT","description":"FDA advisers weigh the first use of psychedelic therapy for post-traumatic stress disorder, review safety and efficacy data from MDMA trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/","og_locale":"en_US","og_type":"article","og_title":"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD","og_description":"An FDA advisory committee is meeting today to review MDMA-assisted psychotherapy to treat PTSD. Follow STAT's live blog throughout the day for updates.","og_url":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/","og_site_name":"STAT","article_publisher":"https:\/\/www.facebook.com\/statnews\/","article_published_time":"2024-06-04T08:30:38+00:00","article_modified_time":"2024-06-05T00:15:28+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065-1024x576.jpeg","type":"image\/jpeg"}],"author":"Olivia Goldhill, Meghana Keshavan","twitter_card":"summary_large_image","twitter_creator":"@OliviaGoldhill","twitter_site":"@statnews","twitter_misc":{"Written by":"Olivia Goldhill, Meghana Keshavan","Est. reading time":"31 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#article","isPartOf":{"@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/"},"author":{"name":"Olivia Goldhill","@id":"https:\/\/www.statnews.com\/#\/schema\/person\/1015d5fce9ad8ee748ec30c3c2a6cd72"},"headline":"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD","datePublished":"2024-06-04T08:30:38+00:00","dateModified":"2024-06-05T00:15:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/"},"wordCount":7065,"publisher":{"@id":"https:\/\/www.statnews.com\/#organization"},"image":{"@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg","keywords":["FDA","Mental Health","psychedelics","STAT+"],"articleSection":["Pharma"],"inLanguage":"en-US","isAccessibleForFree":"False","hasPart":{"@type":"WebPageElement","isAccessibleForFree":"False","cssSelector":".restricted-content-text"},"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/www.statnews.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/","url":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/","name":"MDMA therapy for PTSD voted down by FDA advisory panel | STAT","isPartOf":{"@id":"https:\/\/www.statnews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage"},"image":{"@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg","datePublished":"2024-06-04T08:30:38+00:00","dateModified":"2024-06-05T00:15:28+00:00","description":"FDA advisers weigh the first use of psychedelic therapy for post-traumatic stress disorder, review safety and efficacy data from MDMA trials.","breadcrumb":{"@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2023\/09\/AdobeStock_194264065.jpeg","width":4608,"height":2592,"caption":"MDMA-Assisted Psychotherapy for PTSD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.statnews.com\/2024\/06\/04\/fda-advisory-panel-mdma-therapy-ptsd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.statnews.com\/"},{"@type":"ListItem","position":2,"name":"FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD"}]},{"@type":"WebSite","@id":"https:\/\/www.statnews.com\/#website","url":"https:\/\/www.statnews.com\/","name":"STAT","description":"A decade of reporting from the frontiers of health and medicine","publisher":{"@id":"https:\/\/www.statnews.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.statnews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.statnews.com\/#organization","name":"STAT","url":"https:\/\/www.statnews.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png","width":150,"height":41,"caption":"STAT"},"image":{"@id":"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/statnews\/","https:\/\/x.com\/statnews","https:\/\/www.linkedin.com\/company\/stat-news\/","https:\/\/www.youtube.com\/channel\/UC89FjSf9AT1O2qw6vxrrxDQ"],"description":"STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories from the places that matter to our readers \u2014 research labs, hospitals, executive suites, and political campaigns.","legalName":"STAT","foundingDate":"2015-11-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"}},{"@type":"Person","@id":"https:\/\/www.statnews.com\/#\/schema\/person\/1015d5fce9ad8ee748ec30c3c2a6cd72","name":"Olivia Goldhill","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.statnews.com\/#\/schema\/person\/image\/5ddade59f324409939901b2bc344abeb","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/olivia-g-profile-96x96.png","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/olivia-g-profile-96x96.png","caption":"Olivia Goldhill"},"description":"Olivia Goldhill is a former contributing writer for STAT, focused primarily on covering the health crisis affecting American boys and men. She also covers psychedelic medicines. Previously, she was an investigative reporter at STAT, and covered mental health, reproductive health, and the Covid-19 pandemic. Her work has been recognized with Livingston, EPPY, British Journalism, and Medical Journalists\u2019 Association award nominations, and she was a 2024 New America National Fellow, supported by the Jonathan Logan Family Foundation.","sameAs":["https:\/\/x.com\/OliviaGoldhill"],"url":"https:\/\/www.statnews.com\/staff\/olivia-goldhill\/"}]}},"_links":{"self":[{"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/posts\/1165319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/users\/453"}],"replies":[{"embeddable":true,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/comments?post=1165319"}],"version-history":[{"count":59,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/posts\/1165319\/revisions"}],"predecessor-version":[{"id":1166318,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/posts\/1165319\/revisions\/1166318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/media\/1066056"}],"wp:attachment":[{"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/media?parent=1165319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/categories?post=1165319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/tags?post=1165319"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/authors?post=1165319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}